Haibin Pharma Announces European Approval for Bulk Antibiotic

Published: Dec 02, 2011

December 2, 2011 -- Shenzhen Haibin Pharma received a EU-GMP certificate from Germany allowing it to sell its meropenem bulk drug in Europe. Meropenem is a broad spectrum antibiotic. Haibin said it is the first China company to be granted European approval for meopenem bulk medicine. Currently, Haibin supplies almost 50% of China’s meropenem needs, and it exports to many areas of the world as well. Haibin is a subsidiary of Joincare Pharma. More details....

Stock Symbol: (SHA: 600380)

Back to news